Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Leukemia can sometimes appear as unusual skin issues in children.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Quercetin effectively treated and prevented hair loss in mice.

Targeting Vδ1+T-cells may help treat alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.